What to expect when you take Lorazepam and have Deep venous thrombosis?

Do you take Lorazepam and have Deep venous thrombosis? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and find Care Guides.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Sep, 14, 2018

21,655 reports have been studied.


Females aged 50 to 59 :

13,827 related reports were analyzed:

Most common symptoms:

Depression
  • 5.66% for females aged 50 (±5) who take Lorazepam
Diarrhea
  • 6.5% for females aged 50 (±5) who take Lorazepam
Dizziness
  • 6.12% for females aged 50 (±5) who take Lorazepam
Drug ineffective
  • 5.01% for females aged 50 (±5) who take Lorazepam
Dyspnea
  • 5.91% for females aged 50 (±5) who take Lorazepam
Fatigue
  • 8.51% for females aged 50 (±5) who take Lorazepam
Fever
  • 5.3% for females aged 50 (±5) who take Lorazepam
Headache
  • 6.84% for females aged 50 (±5) who take Lorazepam
Insomnia
  • 5.09% for females aged 50 (±5) who take Lorazepam
Nausea
  • 11.52% for females aged 50 (±5) who take Lorazepam
Nausea and vomiting
  • 5.94% for females aged 50 (±5) who take Lorazepam
Pain
  • 7.06% for females aged 50 (±5) who take Lorazepam
Weakness
  • 6.67% for females aged 50 (±5) who take Lorazepam

Most common co-existing conditions:

Bipolar disorder
  • 5.62% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Breast cancer
  • 17.42% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Breast cancer metastatic
  • 15.17% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Discomfort
  • 9.55% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Granulocyte count decreased
  • 8.99% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
High blood pressure
  • 6.52% for females aged 50 (±5) who take Lorazepam
Hot flush
  • 11.8% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Migraine
  • 11.24% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Multiple myeloma
  • 5.62% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Nausea
  • 13.48% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Neoplasm malignant
  • 9.55% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Osteoporosis
  • 11.8% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Ovarian cancer
  • 12.92% for females aged 50 (±5) who take Lorazepam and have deep venous thrombosis
back to top

Males aged 50 to 59 :

7,828 related reports were analyzed:

Most common symptoms:

Depression
  • 5.24% for males aged 50 (±5) who take Lorazepam
Diarrhea
  • 5.32% for males aged 50 (±5) who take Lorazepam
Dyspnea
  • 6.01% for males aged 50 (±5) who take Lorazepam
Fatigue
  • 8.96% for males aged 50 (±5) who take Lorazepam
Fever
  • 5.47% for males aged 50 (±5) who take Lorazepam
Nausea
  • 7.22% for males aged 50 (±5) who take Lorazepam
Pain
  • 5.76% for males aged 50 (±5) who take Lorazepam
Weakness
  • 5.3% for males aged 50 (±5) who take Lorazepam

Most common co-existing conditions:

Constipation
  • 5.92% for males aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Depression
  • 8.25% for males aged 50 (±5) who take Lorazepam
High blood pressure
  • 5.95% for males aged 50 (±5) who take Lorazepam
Metastases to bone
  • 10.53% for males aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Nausea
  • 13.82% for males aged 50 (±5) who take Lorazepam and have deep venous thrombosis
Nausea and vomiting
  • 5.26% for males aged 50 (±5) who take Lorazepam and have deep venous thrombosis
back to top

Related studies

lorazepam

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. (latest outcomes from Lorazepam 91,719 users)

deep venous thrombosis

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) has been reported by people with birth control, multiple myeloma, pain, high blood pressure, deep venous thrombosis (latest reports from 91,158 Deep venous thrombosis patients).

Lorazepam and Deep venous thrombosis

Analysis tools (to study 506 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Lorazepam, Deep venous thrombosis

Recent updates

General studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.